121 related articles for article (PubMed ID: 12824863)
21. Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs.
Bussenot I; Azoulay-Barjonet C; Parinaud J
J Clin Endocrinol Metab; 1993 May; 76(5):1376-9. PubMed ID: 8496332
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
[TBL] [Abstract][Full Text] [Related]
23. The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.
Diedrich K; Ludwig M; Felberbaum RE
Semin Reprod Med; 2001 Sep; 19(3):213-20. PubMed ID: 11679902
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy-associated plasma protein-a is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum.
Conover CA; Faessen GF; Ilg KE; Chandrasekher YA; Christiansen M; Overgaard MT; Oxvig C; Giudice LC
Endocrinology; 2001 May; 142(5):2155. PubMed ID: 11316785
[TBL] [Abstract][Full Text] [Related]
25. Effect of follicle size on in vitro production of steroids and insulin-like growth factor (IGF)-I, IGF-II, and the IGF-binding proteins by equine ovarian granulosa cells.
Davidson TR; Chamberlain CS; Bridges TS; Spicer LJ
Biol Reprod; 2002 Jun; 66(6):1640-8. PubMed ID: 12021042
[TBL] [Abstract][Full Text] [Related]
26. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
Itskovitz-Eldor J; Kol S; Mannaerts B
Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor (IGF)-independent effects of IGF binding protein-4 on human granulosa cell steroidogenesis.
Wright RJ; Holly JM; Galea R; Brincat M; Mason HD
Biol Reprod; 2002 Sep; 67(3):776-81. PubMed ID: 12193384
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
[TBL] [Abstract][Full Text] [Related]
29. GnRH antagonist cetrorelix inhibits mitochondria-dependent apoptosis triggered by chemotherapy in granulosa cells of rats.
Zhao XJ; Huang YH; Yu YC; Xin XY
Gynecol Oncol; 2010 Jul; 118(1):69-75. PubMed ID: 20417958
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-II participates in the biphasic effect of a gonadotropin-releasing hormone agonist on ovarian cancer cell growth.
Ho MN; Delgado CH; Owens GA; Steller MA
Fertil Steril; 1997 May; 67(5):870-6. PubMed ID: 9130892
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone-I or -II interacts with IGF-I/Akt but not connexin 43 in human granulosa cell apoptosis.
Hong IS; Klausen C; Cheung AP; Leung PC
J Clin Endocrinol Metab; 2012 Feb; 97(2):525-34. PubMed ID: 22112812
[TBL] [Abstract][Full Text] [Related]
32. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?
Lin Y; Kahn JA; Hillensjö T
Hum Reprod; 1999 Apr; 14(4):885-8. PubMed ID: 10221213
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors.
Lamharzi N; Schally AV; Koppán M
Regul Pept; 1998 Oct; 77(1-3):185-92. PubMed ID: 9809814
[TBL] [Abstract][Full Text] [Related]
34. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.
Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192
[TBL] [Abstract][Full Text] [Related]
35. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.
Kovacs M; Schally AV
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12197-202. PubMed ID: 11593037
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction.
Jiang J; Gao S; Xu J
Med Sci Monit; 2018 Nov; 24():7996-8000. PubMed ID: 30405094
[TBL] [Abstract][Full Text] [Related]
37. Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist.
Marci R; Lisi F; Soave I; Lo Monte G; Patella A; Caserta D; Moscarini M
Gynecol Endocrinol; 2012 Oct; 28(10):792-5. PubMed ID: 22397576
[TBL] [Abstract][Full Text] [Related]
38. Regulation of insulin-like growth factor binding protein production by human luteinizing granulosa cells cultured in defined medium.
Cataldo NA; Woodruff TK; Giudice LC
J Clin Endocrinol Metab; 1993 Jan; 76(1):207-15. PubMed ID: 7678423
[TBL] [Abstract][Full Text] [Related]
39. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
[TBL] [Abstract][Full Text] [Related]
40. Effect of LHRH and its analogues on the progesterone secretion of human granulosa cells in vitro.
Török A; Hamori M; Bódis J; Cledon P; Tinneberg HR; Hanf V
Gynecol Obstet Invest; 1992; 34(4):222-4. PubMed ID: 1487180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
